Events

CARB-X speakers include Ed Buurman, Alliance Director. Topics covered include: How big is the problem economically speaking? Should we phase out broad-spectrum antibiotics? Programmatic & technical challenges What can vaccines bring? Click here to view the agenda. Click here to learn more. Click here to register.

To learn more, click here. To view the program, click here. To register, click here.

The 38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID 2020) will be held on 26-29 October 2020 as a fully virtual meeting. The organization of the meeting is a joint effort of ESPID members from the Netherlands. The ESPID forms the basis for investigators interested in infectious diseases in children and infection prevention in childhood. […]

BARDA Industry Day is the annual meeting held to increase potential partner’s awareness of U.S. Government medical countermeasure priorities, interact with BARDA and ASPR staff, and network with public and private sector colleagues working in the Health Security space. This year,  BARDA Industry Day 2020 will be virtual and will feature one day of exciting […]

Speakers: Phoebe Williams, Sydney Children's Hospital and University of Sydney (Australia), will discuss: Status quo – what antibiotics do we have (left) for children and babies Where is the biggest medical need? Challenges of clinical trials in children – the clinicians perspective What impact will new drugs have in day-to-day practice and how does this […]

Panelists include Erin Duffy, CARB-X Chief of R&D Please join us for a special ICARe webinar in light of the course’s 5th anniversary.  This two-hour event, hosted by ICARe director Patrice Courvalin (Institut Pasteur, France), will feature four 20-minute presentations from leading experts in antimicrobial resistance and antibiotic discovery research. Presentations will follow with a […]

Panelists include Erin Duffy, CARB-X Chief of R&D AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are […]

The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled “Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs.” The purpose of the meeting is to obtain early input from the public on a […]

Join us Tuesday, November 17, at 10 AM – 11 AM ET for an update on CARB-X, and an insider’s look at 3 innovative programs supported by CARB-X CARB-X is hosting this special webinar to showcase some of the exciting science in the CARB-X portfolio and the progress CARB-X is making supporting the development of […]

Speakers: James J. Collins, Termeer Professor of Medical Engineering & Science Professor, Broad Institute of MIT and Harvard (USA) Cesar de la Fuente, Presidential Assistant Professor, University of Pennsylvania (USA) Henriette Willems, Senior Research Associate, The ALBORADA Drug Discovery Institute, University of Cambridge, (UK) Fredrik Svensson, Senior Research Associate, UCL Drug Discovery Institute, London, (UK) […]